Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection
- PMID: 12045674
- DOI: 10.1097/00004647-200206000-00014
Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection
Abstract
The selectivity of [18F]MPPF (fluorine-18-labeled 4-(2;-methoxyphenyl)-1-[2;-(N-2"-pirydynyl)-p-fluorobenzamido]ethylpiperazine) for serotonergic 5-hydroxytryptamine(1A) (5-HT1A) receptors has been established in animals and humans. The authors quantified the parameters of ligand-receptor exchanges using a double-injection protocol. After injection of a tracer and a coinjection dose of [18F]MPPF, dynamic positron emission tomography (PET) data were acquired during a 160-minute session in five healthy males. These PET and magnetic resonance imaging data were coregistered for anatomical identification. A three-compartment model was used to determine six parameters: Fv (vascular fraction), K1, k2 (plasma/free compartment exchange rate), koff, kon/Vr (association and dissociation rate), Bmax (receptor concentration), and to deduce Kd (apparent equilibrium dissociation rate). The model was fitted with regional PET kinetics and arterial input function corrected for metabolites. Analytical distribution volume and binding potential were compared with indices generated by Logan-Patlak graphical analysis. The 5HT1A specificity for MPPF was evidenced. A Bmax of 2.9 pmol/mL and a Kd of 2.8 nmol/L were found in hippocampal regions, Kd and distribution volume in the free compartment were regionally stable, and the Logan binding potential was linearly correlated to Bmax. This study confirms the value of MPPF in the investigation of normal and pathologic systems involving the limbic network and 5-HT1A receptors. Standard values can be used for the simulation of simplified protocols.
Similar articles
-
Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats.J Neurochem. 2000 Aug;75(2):803-11. doi: 10.1046/j.1471-4159.2000.0750803.x. J Neurochem. 2000. PMID: 10899958
-
On the quantification of [18F]MPPF binding to 5-HT1A receptors in the human brain.J Nucl Med. 2001 Jul;42(7):1025-31. J Nucl Med. 2001. PMID: 11438622
-
In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF.J Nucl Med. 2000 Nov;41(11):1830-5. J Nucl Med. 2000. PMID: 11079490
-
[18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain.Neuropharmacology. 2007 Mar;52(3):695-707. doi: 10.1016/j.neuropharm.2006.09.023. Epub 2006 Nov 13. Neuropharmacology. 2007. PMID: 17101155 Review.
-
4-(2´-Methoxyphenyl)-1-[2´-(N-2´´-pyridinyl)-p-[18F]fluorobenzamido]ethylpiperazine.2005 Dec 20 [updated 2008 Mar 10]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2005 Dec 20 [updated 2008 Mar 10]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641592 Free Books & Documents. Review.
Cited by
-
5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study.Behav Brain Funct. 2010 Jul 7;6:37. doi: 10.1186/1744-9081-6-37. Behav Brain Funct. 2010. PMID: 20609217 Free PMC article.
-
Serotonin 1A receptors in the living brain of Alzheimer's disease patients.Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):702-7. doi: 10.1073/pnas.0510237103. Epub 2006 Jan 9. Proc Natl Acad Sci U S A. 2006. PMID: 16407119 Free PMC article.
-
Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and Challenges.Pharmaceuticals (Basel). 2023 Dec 11;16(12):1715. doi: 10.3390/ph16121715. Pharmaceuticals (Basel). 2023. PMID: 38139840 Free PMC article. Review.
-
Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate.J Cereb Blood Flow Metab. 2012 Aug;32(8):1546-58. doi: 10.1038/jcbfm.2012.43. Epub 2012 Apr 4. J Cereb Blood Flow Metab. 2012. PMID: 22472611 Free PMC article.
-
A 3D brain unit model to further improve prediction of local drug distribution within the brain.PLoS One. 2020 Sep 23;15(9):e0238397. doi: 10.1371/journal.pone.0238397. eCollection 2020. PLoS One. 2020. PMID: 32966285 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
